RWD-INTEGRATED RANDOMIZED CLINICAL TRIAL ANALYSIS

Overview

Journal Biopharm Rep

Date 2023 Mar 15

PMID 36920164

Authors

Shu Yang

Xiaofei Wang

Affiliations

Soon will be listed here.

Citing Articles

When does adjusting covariate under randomization help? A comparative study on current practices.

Gao Y, Liu Y, Matsouaka R BMC Med Res Methodol. 2024; 24(1):250.

PMID: 39462370 PMC: 11514882. DOI: 10.1186/s12874-024-02375-3.

Response to comment on "Transporting survival of an HIV clinical trial to the external target populations by Lee et al. (2024)".

Yang S, Zhang X J Biopharm Stat. 2024; 1-5.

PMID: 38973566 PMC: 11707040. DOI: 10.1080/10543406.2024.2373449.

References

Yang S . Semiparametric estimation of structural nested mean models with irregularly spaced longitudinal observations. Biometrics. 2021; 78(3):937-949. PMC: 8661109. DOI: 10.1111/biom.13471. View

Morgensztern D, Du L, Waqar S, Patel A, Samson P, Devarakonda S . Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC. J Thorac Oncol. 2016; 11(10):1729-35. PMC: 5141602. DOI: 10.1016/j.jtho.2016.05.022. View

Stuart E, Cole S, Bradshaw C, Leaf P . The use of propensity scores to assess the generalizability of results from randomized trials. J R Stat Soc Ser A Stat Soc. 2014; 174(2):369-386. PMC: 4051511. DOI: 10.1111/j.1467-985X.2010.00673.x. View

Wu L, Yang S . Transfer learning of individualized treatment rules from experimental to real-world data. J Comput Graph Stat. 2023; 32(3):1036-1045. PMC: 10664843. DOI: 10.1080/10618600.2022.2141752. View

Yang S, Zhang Y . Multiply robust matching estimators of average and quantile treatment effects. Scand Stat Theory Appl. 2023; 50(1):235-265. PMC: 9949738. DOI: 10.1111/sjos.12585. View

Dahabreh I, Hernan M . Extending inferences from a randomized trial to a target population. Eur J Epidemiol. 2019; 34(8):719-722. DOI: 10.1007/s10654-019-00533-2. View

Strauss G, Herndon 2nd J, Maddaus M, Johnstone D, Johnson E, Harpole D . Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008; 26(31):5043-51. PMC: 2652093. DOI: 10.1200/JCO.2008.16.4855. View

Yang S, Kim J, Song R . Doubly robust inference when combining probability and non-probability samples with high dimensional data. J R Stat Soc Series B Stat Methodol. 2020; 82(2):445-465. PMC: 7644042. DOI: 10.1111/rssb.12354. View

Lee D, Yang S, Dong L, Wang X, Zeng D, Cai J . Improving trial generalizability using observational studies. Biometrics. 2021; 79(2):1213-1225. PMC: 9166225. DOI: 10.1111/biom.13609. View

10.

Yang S, Gao C, Zeng D, Wang X . Elastic integrative analysis of randomised trial and real-world data for treatment heterogeneity estimation. J R Stat Soc Series B Stat Methodol. 2023; 85(3):575-596. PMC: 10376438. DOI: 10.1093/jrsssb/qkad017. View

11.

Yang S, Ding P . Combining Multiple Observational Data Sources to Estimate Causal Effects. J Am Stat Assoc. 2020; 115(531):1540-1554. PMC: 7571608. DOI: 10.1080/01621459.2019.1609973. View

12.

Katz A, Saad E . CALGB 9633: an underpowered trial with a methodologically questionable conclusion. J Clin Oncol. 2009; 27(13):2300-1. DOI: 10.1200/JCO.2008.21.1565. View

13.

Dahabreh I, Robertson S, Tchetgen E, Stuart E, Hernan M . Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals. Biometrics. 2018; 75(2):685-694. PMC: 10938232. DOI: 10.1111/biom.13009. View